Back to top
more

CONMED Corporation (CNMD)

(Delayed Data from NYSE)

$136.99 USD

136.99
316,163

+0.21 (0.15%)

Updated Jun 16, 2021 04:00 PM ET

After-Market: $137.00 +0.01 (0.01%) 5:24 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy25.41%
2Buy19.02%
3Hold10.72%
4Sell6.46%
5Strong Sell3.06%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 43% (109 out of 251)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Balance Sheet

Research for CNMD

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for CONMED Corporation falls in the month of December.

All items in Millions except Per Share data.

12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Assets          
Cash & Equivalents 27 26 18 33 27
Receivables 177 189 182 167 148
Notes Receivable 0 0 0 0 0
Inventories 195 165 155 141 136
Other Current Assets 17 18 21 16 19
Total Current Assets 417 397 374 357 331
Net Property & Equipment 111 119 113 116 122
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 7 6 5 5 4
Intangibles 1,120 1,151 814 817 817
Deposits & Other Assets 97 102 63 63 56
Total Assets 1,752 1,775 1,369 1,358 1,329
Liabilities & Shareholders Equity 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Notes Payable 0 0 0 0 0
Accounts Payable 53 56 54 42 42
Current Portion Long-Term Debt 18 14 18 15 10
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 50 54 43 34 32
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 68 65 46 59 30
Total Current Liabilities 190 188 161 150 114
Mortgages 0 0 0 0 0
Deferred Taxes/Income 58 74 81 78 119
Convertible Debt 0 0 0 0 0
Long-Term Debt 735 755 439 472 488
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 59 47 26 27 27
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 1,043 1,065 707 727 748
Shareholders Equity 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 383 379 342 334 329
Retained Earnings 457 471 465 440 407
Other Equity -64 -59 -56 -49 -59
Treasury Stock 68 81 89 94 97
Total Shareholder's Equity 709 710 662 631 581
Total Liabilities & Shareholder's Equity 1,752 1,775 1,369 1,358 1,329
Total Common Equity 709 710 662 631 581
Shares Outstanding 28.60 28.30 28.10 27.90 27.80
Book Value Per Share 24.79 25.10 23.57 22.63 20.88

Fiscal Year End for CONMED Corporation falls in the month of December.

All items in Millions except Per Share data.

3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020
Assets          
Cash & Equivalents 37 27 36 35 24
Receivables 164 177 167 143 167
Notes Receivable 0 0 0 0 0
Inventories 206 195 183 176 175
Other Current Assets 18 17 19 25 28
Total Current Assets 424 417 404 379 393
Net Property & Equipment 109 111 112 113 114
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 7 0 0 0
Intangibles 1,112 1,120 1,127 1,134 1,141
Deposits & Other Assets 101 97 100 98 103
Total Assets 1,747 1,752 1,743 1,724 1,751
Liabilities & Shareholders Equity 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020
Notes Payable 0 0 0 0 0
Accounts Payable 56 53 57 40 57
Current Portion Long-Term Debt 20 18 17 15 14
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 41 50 45 37 35
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 65 68 60 59 54
Total Current Liabilities 182 190 179 151 160
Mortgages 0 0 0 0 0
Deferred Taxes/Income 57 58 73 65 72
Convertible Debt 0 0 0 0 0
Long-Term Debt 725 735 760 790 773
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 57 48 43 44
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 1,021 1,043 1,060 1,049 1,049
Shareholders Equity 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 389 383 381 377 375
Retained Earnings 461 457 439 438 471
Other Equity -63 -64 -62 -64 -66
Treasury Stock 62 68 76 77 78
Total Shareholder's Equity 726 709 683 675 702
Total Liabilities & Shareholder's Equity 1,747 1,752 1,743 1,724 1,751
Total Common Equity 726 709 683 675 702
Shares Outstanding 29.00 28.60 28.60 28.50 28.50
Book Value Per Share 25.02 24.79 23.89 23.68 24.62